CSIMarket
 
Molecular Templates inc   (MTEM)
Other Ticker:  
 
 
Price: $2.2900 $-0.10 -4.184%
Day's High: $2.476 Week Perf: 30.11 %
Day's Low: $ 2.04 30 Day Perf: -42.24 %
Volume (M): 28 52 Wk High: $ 9.15
Volume (M$): $ 64 52 Wk Avg: $3.36
Open: $2.39 52 Wk Low: $0.33



 Market Capitalization (Millions $) 12
 Shares Outstanding (Millions) 5
 Employees 45
 Revenues (TTM) (Millions $) 18
 Net Income (TTM) (Millions $) 75
 Cash Flow (TTM) (Millions $) -7
 Capital Exp. (TTM) (Millions $) 1

Molecular Templates Inc
Molecular Templates Inc. is a clinical-stage biopharmaceutical company that is focused on the discovery, development, and commercialization of targeted biologic therapeutics. The company is based in Austin, Texas and was founded in 2016 by Eric Poma, a molecular biology professor at the University of Texas.

Molecular Templates has developed a proprietary platform technology known as Engineered Toxin Bodies (ETBs) that is designed to combine the targeting ability of an antibody with the cytotoxicity of a bacterial toxin. These ETBs are able to selectively target and destroy cancer cells while sparing healthy cells, making them an attractive option for cancer therapy.

The company has several ETB-based product candidates in clinical development for the treatment of various types of cancer, including Non-Hodgkin's Lymphoma (NHL), multiple myeloma, and solid tumors. One of its leading product candidates, MT-3724, is an ETB targeting CD20, a protein that is overexpressed on the surface of NHL cells.

Molecular Templates has also developed a bi-specific ETB technology that enables specific targeting of cancer cells with two different binding sites, potentially increasing the therapeutic benefit. The company is further exploring the potential of its ETB platform technology to develop therapeutics for the treatment of other diseases besides cancer.

In addition to its product pipeline, Molecular Templates has established collaborations with several companies and academic institutions to further advance its technology and platform. The company has also secured several patents related to its ETB platform technology.

Molecular Templates is led by a team of experienced executives and scientists who have a strong track record in biopharmaceutical drug discovery and development. The company is well-funded with over $180 million in cash and investments as of June 2021, which provides it with the financial resources to advance its product pipeline and research programs.

Overall, Molecular Templates is a promising biopharmaceutical company that is developing innovative and targeted therapies for the treatment of cancer and other diseases. Its unique ETB platform technology has the potential to transform the field of cancer therapeutics and improve patient outcomes.


   Company Address: 9301 Amberglen Blvd Austin 78729 TX
   Company Phone Number: 869-1555   Stock Exchange / Ticker: NASDAQ MTEM
   


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
• View Complete Report
   



Financing Agreement

Molecular Templates Announces $9.5 Million Private Placement Offering and Agreement to Amend Second Tranche of July 2023 Purchase Agreement, Paving the Way for Accelerated Research and Development Efforts in Novel Cancer Therapies.

Published Thu, Mar 28 2024 12:11 PM UTC


Molecular Templates, a leading biopharmaceutical company based in Austin, Texas, has recently announced a definitive amended and restated securities purchase agreement with several healthcare investors. This agreement is set to provide a substantial $9.5 million in gross proceeds to Molecular Templates through the closing of the second tranche of its previously announce...






 

Molecular Templates Inc's Segments
 
 
• View Complete Report




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com